Search
for
Sort by
Research 31–60 of 44
- Mechanism-Based Strategies for Prevention of Taxane-Induced Hair Follicle Damage in Cancer Chemotherapy
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- CDK4/6 inhibition mitigates stem cell damage in a novel model for taxane‐induced alopecia
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- Anticancer agents against malaria: time to revisit?
- Madarosis: A marker of many Maladies
- Chrysin Increases the Therapeutic Efficacy of Docetaxel and Mitigates Docetaxel-Induced Edema
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Pilomatrix Carcinoma: Report of Two Cases of the Head and Review of the Literature
- Comparison of pemetrexed and docetaxel as salvage chemotherapy for the treatment for nonsmall-cell lung cancer after the failure of epidermal growth factor receptor-tyrosine kinase inhibitors
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- Improving preparation for scalp cooling: Learning from women undergoing chemotherapy for early‐stage breast cancer—The COOL study
- Role of sgk1 in cancer: a bibliometric analysis from 2013 to 2023—review article
- Chemotherapy-Induced Alopecia in Breast Cancer Patients: Treatment-Specific Incidence and Risk of Persistent Hair Loss
- Dermatological adverse events with taxane chemotherapy
- Permanent chemotherapy-induced alopecia: Case report and review of the literature
- Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer
- Cutaneous Reactions to Chemotherapeutic Agents
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Cutaneous angiosarcoma of the face and scalp presenting as alopecia
- High incidence of severe hand–foot syndrome during capecitabine–docetaxel combination chemotherapy
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- 203 Inhibin A is downregulated during chemotherapy in patients with breast cancer
- Docetaxel.
- An overview of management of drug-induced hair and nail disorders
- Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
- Low Intensity Ultrasound as an Antidote to Taxane/Paclitaxel-induced Cytotoxicity
- Mucocutaneous reactions to chemotherapy
- Hair and cancer chemotherapy: consequences and nursing care - a literature study